Terifrac Teriparatide 750 Mcg Injection

Get a Price/Quote

MOQ : 10 Pieces

Terifrac Teriparatide 750 Mcg Injection Specification

Pacakaging (Quantity Per Box)
1 Cartridge

Life Span
Check expiry date on packaging

Origin of Medicine
India

Brand Name
Terifrac

Packaging Type
Cartridge

Indication
Osteoporosis, fracture risk reduction

Salt Composition
Teriparatide 750 mcg

Dosage Form
Injection

Drug Type
Biologic therapy

Ingredients
Teriparatide (rDNA origin)

Physical Form
Injection

Function
Parathyroid hormone analog for bone formation

Recommended For
Used in treatment of osteoporosis in postmenopausal women and men at increased risk of fracture

Dosage
750 mcg/3ml (250 mcg per ml)

Dosage Guidelines
As directed by the physician

Suitable For
Adults

Quantity
1 Cartridge (3 ml)

Storage Instructions
Store in a refrigerator (2C - 8C). Do not freeze.

Color of Solution
Clear, colorless

Mode of Administration
Subcutaneous injection

Caution
Not recommended for pediatric use or patients with increased risk of osteosarcoma

Injection Volume
3 ml

Therapeutic Class
Osteoporosis Therapeutic Agents

Prescription Status
Prescription only

Molecular Formula
C181H291N55O51S2

Duration of Use
Usually 24 months or as directed

Marketed In
Canada, Europe, UK, USA, Australia, India

Terifrac Teriparatide 750 Mcg Injection About

Terifrac Teriparatide 750 Mcg Injection, highly in demand for treating osteoporosis, is an affordable solution designed to deliver formidable bone strength. This immaculate, biologic therapy offers lavish care for postmenopausal women and men at increased fracture risk. Administered subcutaneously, Terifrac's clear, colorless solution ensures rapid absorption at the prescribed dosage. Available in a convenient 3 ml cartridge, it provides precise, effective treatment over a recommended 24-month duration. Purchase this reliable, prescription-only medicine, manufactured in India, and join patients worldwide benefiting from its advanced therapeutic performance.

Reliable Osteoporosis Treatment for Adults

Terifrac Teriparatide 750 Mcg Injection is suitable for adult usage and specifically recommended for osteoporosis in postmenopausal women and men at high fracture risk. The main feature lies in its parathyroid hormone analog composition, stimulating new bone formation. Offered in a clear, colorless 3 ml cartridge, it guarantees exact dosing through subcutaneous administration. Terifrac is stored refrigerated to preserve its immaculate quality, ensuring the efficacy of every dose administered under physician guidance.

Global Distribution and Supply Features

Terifrac Teriparatide 750 Mcg Injection is actively exported to multiple markets, including Canada, Europe, the UK, USA, Australia, and India. Both export and domestic transactions benefit from attractive sale prices. Orders are reliably delivered and drop-off is available for convenient distribution. Our supply ability facilitates prompt dispatch, meeting high demand for this prescription biologic and ensuring that every cartridge reaches customers in pristine condition, wherever they are located.

FAQ's of Terifrac Teriparatide 750 Mcg Injection:

Q: How should Terifrac Teriparatide 750 Mcg Injection be administered?

A: Terifrac Teriparatide Injection is best administered as a subcutaneous injection into the thigh or abdomen, strictly as directed by your physician.

Q: What is the main benefit of using Terifrac Teriparatide?

A: The key benefit of Terifrac Teriparatide is its ability to significantly increase bone formation and reduce the risk of fractures in adults with osteoporosis.